Australian Pharmacies and Peptide Compounding

Compounding pharmacies prepare customized medicines by combining, mixing, or modifying pharmaceutical ingredients according to prescriptions from registered medical practitioners. Compounding allows for custom dosing, preparation of medicines in unavailable forms, and combination of multiple active ingredients.

Compounding is regulated in Australia by AHPRA and the TGA.

Compounding pharmacies must be registered and comply with TGA Compounding Standards, which cover quality, safety, and sterility requirements. Pharmacists must be registered with AHPRA. Prescriptions must be from qualified registered practitioners. Records must be maintained.

Compounding standards are less stringent than standards for pharmaceutical manufacturing, but they protect patient safety.

Compounding pharmacies may prepare peptide preparations: reconstituting lyophilised peptides in appropriate solvents, sterilising and filtering solutions, preparing customized doses, or modifying peptide formulations. This is legitimate when done under a valid prescription from a qualified practitioner.

Using compounding to circumvent therapeutic goods regulations (supplying unapproved peptides for therapeutic use) is not lawful.

A doctor prescribes an approved peptide medicine, but a custom dose or formulation is needed. A doctor prescribes an unapproved peptide under the SAS or Authorised Prescriber pathway. A researcher obtains research peptides from a supplier and has them reconstituted under sterile conditions by a compounding pharmacy.

Using a compounding pharmacy to circumvent therapeutic goods regulations — supplying unapproved peptides for therapeutic use without appropriate clinical oversight — is not lawful. The TGA's position is that compounding cannot be used to avoid therapeutic goods regulations.